Mushrooms & Cancer
Explore mushroom research and guides on mushrooms & cancer.
Medicinal Mushrooms as Cancer Adjuncts: A Cross-Species Evidence Overview
Which medicinal mushroom has the strongest cancer evidence? An honest species-by-species ranking: from PSK's 23-RCT meta-analysis to lion's mane's zero clinical trials.
Medicinal Mushrooms in Cancer Treatment: A Complete Guide
Three mushroom compounds are approved anticancer drugs in Japan. A 2017 meta-analysis of 23 RCTs and 10,684 patients shows what they can and cannot do.
Mushroom Compounds That Block Tumor Blood Vessel Growth
Cordycepin blocked tumor growth 40-60% in xenograft mice via FAK/p53. Six compound classes from mushrooms target tumor blood supply by distinct mechanisms.
Mushrooms and Ovarian Cancer: The Preclinical Evidence
What peer-reviewed research shows about mushrooms and ovarian cancer, from the one population study to cell-line experiments where Ganoderma lucidum suppressed VEGF and enhanced cisplatin sensitivity in ovarian cancer cells.
Mushrooms and Pancreatic Cancer: Emerging Research
Research on mushrooms and pancreatic cancer is still emerging. PSK and maitake show early signals. Here is what the evidence shows and where gaps remain.
Mushroom Cancer Adjunct Evidence: A Research Review
Evidence for mushroom cancer adjuncts ranked by study quality: from a 10,684-patient PSK meta-analysis to population data. What the trials show and what they don't.